PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
51.07%
Revenue growth 1.25-1.5x EXP's 34.99%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
119.16%
Gross profit growth above 1.5x EXP's 77.42%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-100.00%
Negative EBIT growth while EXP is at 84.68%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
10650.00%
Operating income growth above 1.5x EXP's 93.86%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
1503.19%
Net income growth above 1.5x EXP's 85.56%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
1400.00%
EPS growth above 1.5x EXP's 88.06%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
1393.33%
Diluted EPS growth above 1.5x EXP's 88.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.28%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
0.15%
Slight or no buyback while EXP is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
318.04%
OCF growth above 1.5x EXP's 117.68%. David Dodd would confirm a clear edge in underlying cash generation.
151.80%
FCF growth under 50% of EXP's 318.59%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
30.07%
10Y revenue/share CAGR under 50% of EXP's 239.77%. Michael Burry would suspect a lasting competitive disadvantage.
92.82%
5Y revenue/share CAGR similar to EXP's 88.22%. Walter Schloss might see both companies benefiting from the same mid-term trends.
-22.83%
Negative 3Y CAGR while EXP stands at 31.63%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
1279.14%
10Y OCF/share CAGR 1.25-1.5x EXP's 911.08%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
241.68%
5Y OCF/share CAGR above 1.5x EXP's 81.96%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
408.16%
3Y OCF/share CAGR above 1.5x EXP's 27.46%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
3324.04%
Net income/share CAGR above 1.5x EXP's 398.35% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
655.30%
5Y net income/share CAGR above 1.5x EXP's 62.76%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-28.57%
Negative 3Y CAGR while EXP is 36.78%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
113.09%
10Y equity/share CAGR in line with EXP's 117.10%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
41.01%
5Y equity/share CAGR at 50-75% of EXP's 77.31%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
21.85%
Below 50% of EXP's 54.55%. Michael Burry suspects a serious short-term disadvantage in building book value.
153.74%
Similar 10Y dividend/share CAGR to EXP's 150.57%. Walter Schloss expects both to share consistent earnings expansions and payout practices.
20.57%
Below 50% of EXP's 151.67%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
-18.96%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
26.24%
AR growth well above EXP's 19.08%. Michael Burry fears inflated revenue or higher default risk in the near future.
1.83%
We show growth while EXP is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
3.97%
Asset growth above 1.5x EXP's 2.38%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
5.99%
1.25-1.5x EXP's 4.77%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
0.96%
We have some new debt while EXP reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
15.66%
SG&A growth well above EXP's 6.06%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.